Key differences between apoC-III regulation and expression in intestine and liver.

about

Key differences between apoC-III regulation and expression in intestine and liver.

Item

http://www.wikidata.org/entity/Q38664013

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Key differences between apoC-III regulation and expression in intestine and liver.

@en

type

Item

label

Key differences between apoC-III regulation and expression in intestine and liver.

@en

prefLabel

Key differences between apoC-III regulation and expression in intestine and liver.

@en

P1476

Key differences between apoC-III regulation and expression in intestine and liver.

@en

P2093

Alison B Kohan

http://www.w3.org/2001/XMLSchema#string

Cayla Rodia

http://www.w3.org/2001/XMLSchema#string

Diana Li

http://www.w3.org/2001/XMLSchema#string

Gabrielle West

http://www.w3.org/2001/XMLSchema#string

Hongli Dong

http://www.w3.org/2001/XMLSchema#string

Zania Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of l

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia

Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes

Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Chylomicrons produced by Caco-2 cells contained ApoB-48 with diameter of 80-200 nm

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures

P304

747-753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2017.07.116

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

491

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28739253

http://www.w3.org/2001/XMLSchema#string

P932

6069593

http://www.w3.org/2001/XMLSchema#string